Paxion Scientific is a start up out of the University of Auckland. With substantial funding from Wellcome Leap we have accelerated the development and validation of a unique cutting-edge healthcare technology. StatOS is a voltammetry platform that allows rapid point-of-care measurment of a suite of oxidative stress biomarkers with wide clinical applicability. This has never been available to clinicians before and represents a major breakthrough as it provides a fundamental measure of patient wellbeing. It will provide significant gains in clinical outcomes and decrease the cost of care. The company has completed 3 clinical trials and at the completion of the current trial will lock down the design and be ready for scaled manufacture, distribution and sales.
At Paxion Scientific, we understand the importance of data-driven insight and connectivity in healthcare. The integrated AI analytics and digital outputs wlll be seamlessly integrated into digital healtchare systems. The workflow impact with StatOS is minimal. By harnessing the latest advancements in digital health technology, we will empower healthcare organizations to deliver more personalized care, optimize workflows, and drive better results.
Our team of experts is committed to staying at the forefront of industry trends and continuously innovating to meet the evolving needs of the healthcare landscape. Paxion Scientific is dedicated to helping healthcare providers deliver high-quality care in a more efficient and effective manner.
Visit our booth at the Digital Health Festival 2026 to learn more about how Paxion Scientific is leading the charge in transforming healthcare through connection. Let us show you how our solutions can help your organization thrive in the digital age and make a real difference in the lives of patients.